Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index

doi:10.3748/wjg.v29.i23.3703

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2425)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

1120

Figures (1-3)

325

Tables (1-2)

256

Sum=1778

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

148

Download

389

Sum=537

Jun 21, 2023 (publication date) through Jun 11, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Jun 21, 2023; 29(23): 3703-3714
Published online Jun 21, 2023. doi: 10.3748/wjg.v29.i23.3703

Table 1 Patients’ characteristics

Patients’ characteristics	n = 107
M/F	61/46
Age (yr)	55.1 ± 15.9
BMI (kg/m²)	26.8 ± 4.1
Metabolic diseases
Diabetes mellitus (yes/no)	25/82
Dyslipidemia (yes/no)	35/72
Hypertension (yes/no)	37/70
Concomitant drugs
SGLT2 inhibitor	12
DPP-4 inhibitor	13
Thiazolidinedione	2
GLP-1 agonist	2
Statin	19
Bezafibrate	0
Pemafibrate	8
EPA and DHA preparation	1
AST (U/L)	44.9 ± 38.0
ALT (U/L)	70.6 ± 57.7
GGT (U/L)	99.6 ± 139.7
T-B (mg/dL)	0.9 ± 0.5
Alb (mg/dL)	4.5 ± 0.4
eGFR (mL/min)	73.0 ± 15.0
HbA1c (%)	6.5 ± 1.2
T-chol (mg/dL)	202.1 ± 52.6
TG (mg/dL)	180.0 ± 119.0
WBC (10³/μL)	6731.8 ± 1882.5
Hb (g/dL)	14.7 ± 1.3
Plts (10⁴/μL)	23.9 ± 7.6
Fib-4 index	1.53 ± 1.90

M: Male; F: Female; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: γ-glutamyltransferase; T-Bil: Total bilirubin; Alb: Albumin; eGFR: Estimated glomerular filtration rate; HbA1c: Glycated hemoglobin A1c; T-chol: Total cholesterol; TG: Triglycerides; WBC: White blood cells; Hb: Hemoglobin; Plts: Platelets.

Citation: Funada K, Kusano Y, Gyotoku Y, Shirahashi R, Suda T, Tamano M. Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index. World J Gastroenterol 2023; 29(23): 3703-3714
URL: https://www.wjgnet.com/1007-9327/full/v29/i23/3703.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i23.3703